4.2 Article

Identifying therapeutic monoclonal antibodies using target protein collision electrophoresis reflex assay to separate the wheat from the chaff

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

Case report: Interference from isatuximab on serum protein electrophoresis prevented demonstration of complete remission in a myeloma patient

Rachel D. Wheeler et al.

Summary: Multiple myeloma, a rare hematological cancer, has seen improved survival rates with novel treatments like anti-CD38 monoclonal antibodies. However, these therapies may interfere with protein electrophoresis, highlighting the need for laboratories to have alternative analytical strategies in place.

ANNALS OF CLINICAL BIOCHEMISTRY (2022)

Editorial Material Medical Laboratory Technology

Perspectives in developments of mass spectrometry for improving diagnosis and monitoring of multiple myeloma and other plasma cell disorders

Francesca Lavatelli et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Oncology

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

David L. Murray et al.

Summary: Mass spectrometry is emerging as a powerful tool in diagnosing and monitoring plasma cell disorders, showing equivalent clinical performance to immunofixation electrophoresis with added benefits of detecting additional risk factors and differentiating therapeutic antibodies. This technology is gaining traction in clinical laboratories and may become the new standard in practice.

BLOOD CANCER JOURNAL (2021)

Article Medical Laboratory Technology

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference

Somayya Noori et al.

Summary: This study addresses the analytical challenges of monitoring M-protein when multiple therapeutic monoclonal antibodies (t-mAbs) are combined for treatment. The double hydrashift assay and MS-MRD assay were used to distinguish M-protein from t-mAbs and provide sensitive and quantitative monitoring.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Use of a Daratumumab-Specific Immunofixation Assay to Assess Possible Immunotherapy Interference at a Major Cancer Center: Our Experience and Recommendations

Daniel C. Kirchhoff et al.

Summary: The study retrospectively examined the use of the Hydrashift assay at a large cancer center and provided guidelines on its most appropriate use. The Hydrashift assay is typically unnecessary in patients with large M-spikes, >0.25 g/dL, regardless of clone type.

JOURNAL OF APPLIED LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Incidence and Management of Therapeutic Monoclonal Antibody Interference in Monoclonal Gammopathy Monitoring

Li Liu et al.

JOURNAL OF APPLIED LABORATORY MEDICINE (2020)

Editorial Material Biotechnology & Applied Microbiology

The Increasingly Human and Profitable Monoclonal Antibody Market

Antonio L. Grilo et al.

TRENDS IN BIOTECHNOLOGY (2019)

Article Multidisciplinary Sciences

Band-collision gel electrophoresis

Dimitri A. Bikos et al.

NATURE COMMUNICATIONS (2019)

Article Medical Laboratory Technology

Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab Assay

Katie L. Thoren et al.

JOURNAL OF APPLIED LABORATORY MEDICINE (2019)

Article Medicine, General & Internal

Multiple myeloma

Shaji K. Kumar et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Medical Laboratory Technology

Identification of Friend or Foe: The Laboratory Challenge of Differentiating M-Proteins from Monoclonal Antibody Therapies

John R. Mills et al.

JOURNAL OF APPLIED LABORATORY MEDICINE (2017)

Article Medical Laboratory Technology

Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference

Christopher McCudden et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)

Article Medical Laboratory Technology

Evaluation of digital images for identification and characterization of monoclonal immunoglobulins by immunofixation

Laura M. Bender et al.

CLINICAL BIOCHEMISTRY (2013)

Letter Medical Laboratory Technology

Interference of Monoclonal Antibody Therapies with Serum Protein Electrophoresis Tests

Christopher R. McCudden et al.

CLINICAL CHEMISTRY (2010)

Review Biochemical Research Methods

Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions

Lance M. Hellman et al.

NATURE PROTOCOLS (2007)